The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Genetic Modification Therapies Market Research Report 2025

Global Genetic Modification Therapies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1717885

No of Pages : 76

Ask Your Query

Synopsis

Genetic modification of humans via gene therapy is becoming a treatment option for diseases ranging from rare metabolic disorders to cancer.

The global Genetic Modification Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Genetic Modification Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Modification Therapies.

Report Scope

The Genetic Modification Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Genetic Modification Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genetic Modification Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • 4D Molecular Therapeutics
  • Abeona Therapeutics
  • Allergan
  • American Gene Technologies
  • Merck Millipore
  • AbbVie

Segment by Type

  • Gene Therapies
  • Genetically Modified Cell Therapies
  • RNA Therapies
  • Gene Editing

Segment by Application

  • Hospitals
  • Diagnostics and Testing Laboratories
  • Academic and Research Organizations
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genetic Modification Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Modification Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gene Therapies
1.2.3 Genetically Modified Cell Therapies
1.2.4 RNA Therapies
1.2.5 Gene Editing
1.3 Market by Application
1.3.1 Global Genetic Modification Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Modification Therapies Market Perspective (2019-2030)
2.2 Genetic Modification Therapies Growth Trends by Region
2.2.1 Global Genetic Modification Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Genetic Modification Therapies Historic Market Size by Region (2019-2024)
2.2.3 Genetic Modification Therapies Forecasted Market Size by Region (2025-2030)
2.3 Genetic Modification Therapies Market Dynamics
2.3.1 Genetic Modification Therapies Industry Trends
2.3.2 Genetic Modification Therapies Market Drivers
2.3.3 Genetic Modification Therapies Market Challenges
2.3.4 Genetic Modification Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Modification Therapies Players by Revenue
3.1.1 Global Top Genetic Modification Therapies Players by Revenue (2019-2024)
3.1.2 Global Genetic Modification Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Modification Therapies Revenue
3.4 Global Genetic Modification Therapies Market Concentration Ratio
3.4.1 Global Genetic Modification Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Modification Therapies Revenue in 2023
3.5 Genetic Modification Therapies Key Players Head office and Area Served
3.6 Key Players Genetic Modification Therapies Product Solution and Service
3.7 Date of Enter into Genetic Modification Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Modification Therapies Breakdown Data by Type
4.1 Global Genetic Modification Therapies Historic Market Size by Type (2019-2024)
4.2 Global Genetic Modification Therapies Forecasted Market Size by Type (2025-2030)
5 Genetic Modification Therapies Breakdown Data by Application
5.1 Global Genetic Modification Therapies Historic Market Size by Application (2019-2024)
5.2 Global Genetic Modification Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Genetic Modification Therapies Market Size (2019-2030)
6.2 North America Genetic Modification Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Genetic Modification Therapies Market Size by Country (2019-2024)
6.4 North America Genetic Modification Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Modification Therapies Market Size (2019-2030)
7.2 Europe Genetic Modification Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Genetic Modification Therapies Market Size by Country (2019-2024)
7.4 Europe Genetic Modification Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Modification Therapies Market Size (2019-2030)
8.2 Asia-Pacific Genetic Modification Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Genetic Modification Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Genetic Modification Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Modification Therapies Market Size (2019-2030)
9.2 Latin America Genetic Modification Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Genetic Modification Therapies Market Size by Country (2019-2024)
9.4 Latin America Genetic Modification Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Modification Therapies Market Size (2019-2030)
10.2 Middle East & Africa Genetic Modification Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Genetic Modification Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Genetic Modification Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 4D Molecular Therapeutics
11.1.1 4D Molecular Therapeutics Company Detail
11.1.2 4D Molecular Therapeutics Business Overview
11.1.3 4D Molecular Therapeutics Genetic Modification Therapies Introduction
11.1.4 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024)
11.1.5 4D Molecular Therapeutics Recent Development
11.2 Abeona Therapeutics
11.2.1 Abeona Therapeutics Company Detail
11.2.2 Abeona Therapeutics Business Overview
11.2.3 Abeona Therapeutics Genetic Modification Therapies Introduction
11.2.4 Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024)
11.2.5 Abeona Therapeutics Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Genetic Modification Therapies Introduction
11.3.4 Allergan Revenue in Genetic Modification Therapies Business (2019-2024)
11.3.5 Allergan Recent Development
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Detail
11.4.2 American Gene Technologies Business Overview
11.4.3 American Gene Technologies Genetic Modification Therapies Introduction
11.4.4 American Gene Technologies Revenue in Genetic Modification Therapies Business (2019-2024)
11.4.5 American Gene Technologies Recent Development
11.5 Merck Millipore
11.5.1 Merck Millipore Company Detail
11.5.2 Merck Millipore Business Overview
11.5.3 Merck Millipore Genetic Modification Therapies Introduction
11.5.4 Merck Millipore Revenue in Genetic Modification Therapies Business (2019-2024)
11.5.5 Merck Millipore Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Genetic Modification Therapies Introduction
11.6.4 AbbVie Revenue in Genetic Modification Therapies Business (2019-2024)
11.6.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Genetic Modification Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gene Therapies
Table 3. Key Players of Genetically Modified Cell Therapies
Table 4. Key Players of RNA Therapies
Table 5. Key Players of Gene Editing
Table 6. Global Genetic Modification Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Genetic Modification Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Genetic Modification Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Genetic Modification Therapies Market Share by Region (2019-2024)
Table 10. Global Genetic Modification Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Genetic Modification Therapies Market Share by Region (2025-2030)
Table 12. Genetic Modification Therapies Market Trends
Table 13. Genetic Modification Therapies Market Drivers
Table 14. Genetic Modification Therapies Market Challenges
Table 15. Genetic Modification Therapies Market Restraints
Table 16. Global Genetic Modification Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Genetic Modification Therapies Market Share by Players (2019-2024)
Table 18. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2023)
Table 19. Ranking of Global Top Genetic Modification Therapies Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Genetic Modification Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Genetic Modification Therapies Product Solution and Service
Table 23. Date of Enter into Genetic Modification Therapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Genetic Modification Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Genetic Modification Therapies Revenue Market Share by Type (2019-2024)
Table 27. Global Genetic Modification Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Genetic Modification Therapies Revenue Market Share by Type (2025-2030)
Table 29. Global Genetic Modification Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Genetic Modification Therapies Revenue Market Share by Application (2019-2024)
Table 31. Global Genetic Modification Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Genetic Modification Therapies Revenue Market Share by Application (2025-2030)
Table 33. North America Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Genetic Modification Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Genetic Modification Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Genetic Modification Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Genetic Modification Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Genetic Modification Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Genetic Modification Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 48. 4D Molecular Therapeutics Company Detail
Table 49. 4D Molecular Therapeutics Business Overview
Table 50. 4D Molecular Therapeutics Genetic Modification Therapies Product
Table 51. 4D Molecular Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
Table 52. 4D Molecular Therapeutics Recent Development
Table 53. Abeona Therapeutics Company Detail
Table 54. Abeona Therapeutics Business Overview
Table 55. Abeona Therapeutics Genetic Modification Therapies Product
Table 56. Abeona Therapeutics Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
Table 57. Abeona Therapeutics Recent Development
Table 58. Allergan Company Detail
Table 59. Allergan Business Overview
Table 60. Allergan Genetic Modification Therapies Product
Table 61. Allergan Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
Table 62. Allergan Recent Development
Table 63. American Gene Technologies Company Detail
Table 64. American Gene Technologies Business Overview
Table 65. American Gene Technologies Genetic Modification Therapies Product
Table 66. American Gene Technologies Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
Table 67. American Gene Technologies Recent Development
Table 68. Merck Millipore Company Detail
Table 69. Merck Millipore Business Overview
Table 70. Merck Millipore Genetic Modification Therapies Product
Table 71. Merck Millipore Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
Table 72. Merck Millipore Recent Development
Table 73. AbbVie Company Detail
Table 74. AbbVie Business Overview
Table 75. AbbVie Genetic Modification Therapies Product
Table 76. AbbVie Revenue in Genetic Modification Therapies Business (2019-2024) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Modification Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Genetic Modification Therapies Market Share by Type: 2023 VS 2030
Figure 3. Gene Therapies Features
Figure 4. Genetically Modified Cell Therapies Features
Figure 5. RNA Therapies Features
Figure 6. Gene Editing Features
Figure 7. Global Genetic Modification Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Genetic Modification Therapies Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Diagnostics and Testing Laboratories Case Studies
Figure 11. Academic and Research Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. Genetic Modification Therapies Report Years Considered
Figure 14. Global Genetic Modification Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Genetic Modification Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Genetic Modification Therapies Market Share by Region: 2023 VS 2030
Figure 17. Global Genetic Modification Therapies Market Share by Players in 2023
Figure 18. Global Top Genetic Modification Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Modification Therapies as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Genetic Modification Therapies Revenue in 2023
Figure 20. North America Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Genetic Modification Therapies Market Share by Country (2019-2030)
Figure 22. United States Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Genetic Modification Therapies Market Share by Country (2019-2030)
Figure 26. Germany Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Genetic Modification Therapies Market Share by Region (2019-2030)
Figure 34. China Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Genetic Modification Therapies Market Share by Country (2019-2030)
Figure 42. Mexico Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Genetic Modification Therapies Market Share by Country (2019-2030)
Figure 46. Turkey Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Genetic Modification Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. 4D Molecular Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
Figure 49. Abeona Therapeutics Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
Figure 50. Allergan Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
Figure 51. American Gene Technologies Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
Figure 52. Merck Millipore Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
Figure 53. AbbVie Revenue Growth Rate in Genetic Modification Therapies Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock